IMMUNEXCITE INC has a total of 24 patent applications. Its first patent ever was published in 2009. It filed its patents most often in EPO (European Patent Office), WIPO (World Intellectual Property Organization) and Australia. Its main competitors in its focus markets pharmaceuticals, biotechnology and measurement are SOLBEC PHARMACEUTICALS LTD, REUTTER WERNER and RADEMACHER GROUP LIMITED.
# | Country | Total Patents | |
---|---|---|---|
#1 | EPO (European Patent Office) | 5 | |
#2 | WIPO (World Intellectual Property Organization) | 4 | |
#3 | Australia | 3 | |
#4 | Canada | 3 | |
#5 | United States | 3 | |
#6 | Mexico | 2 | |
#7 | Brazil | 1 | |
#8 | China | 1 | |
#9 | Israel | 1 | |
#10 | Japan | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Biotechnology | |
#3 | Measurement | |
#4 | Organic fine chemistry | |
#5 | Macromolecular chemistry and polymers |
# | Technology | |
---|---|---|
#1 | Peptides | |
#2 | Therapeutic chemical compounds | |
#3 | Medical preparations | |
#4 | Analysing materials | |
#5 | Polysaccharides | |
#6 | Sugars |
# | Name | Total Patents |
---|---|---|
#1 | Rubin-Bejerano Ifat | 18 |
#2 | Reznik Gabriel Oscar | 12 |
#3 | Siedlecki James Michael | 8 |
#4 | Kane John James | 8 |
#5 | Miao Hua | 8 |
#6 | Dostalova Zuzana | 7 |
#7 | Fink Gerald R | 7 |
#8 | Sansal-Castellano Isabelle | 7 |
#9 | Kluge Arthur F | 5 |
#10 | Ifat Rubin-Bejerano | 4 |
Publication | Filing date | Title |
---|---|---|
US2018154014A1 | Beta-1,6-glucan cetuximab antibody conjugates | |
AU2016209337A1 | Compositions and methods for cancer immunotherapy | |
WO2015172040A2 | IMMUNOMODULATING β-1,6-D-GLUCANS | |
CA2760044A1 | Immunomodulating compositions and methods of use thereof |